Arkolith/Insider Trading/ODTX/Form 4

Opipari Anthony W.

See RemarksOdyssey Therapeutics, Inc. (ODTX) · full profile →Form 4 · filed May 11, 2026
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
10
3 non-derivative · 7 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
May 11, 2026Option exercise(M)541——8K
May 11, 2026Tax withholding(F)4$18.00$728K
May 11, 2026Conversion(C)7K——7K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
May 11, 2026Conversion(C)20K——0
May 11, 2026Conversion(C)18K——0
May 11, 2026Option exercise(M)5K——0
May 11, 2026Conversion(C)19K——0
May 11, 2026Conversion(C)11K——0
May 7, 2026Grant(A)28K—$028K
May 7, 2026Grant(A)250K—$0250K

Transaction Codes

M
Option exercise / conversion
F
Shares withheld for taxes
C
Conversion of a derivative
A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001193125-26-217584) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML